The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation - sprookjes - yvandenbroek - TriplyDB

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation

http://www.wikidata.org/entity/Q24613593

about

In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis.Pharmacological treatment of PTSD - established and new approaches Stress as a one-armed bandit: Differential effects of stress paradigms on the morphology, neurochemistry and behavior in the rodent amygdala.Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus Rett Syndrome: Reaching for Clinical Trials The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study Chronic antidepressant treatment impairs the acquisition of fear extinction.Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior.Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Effects of tianeptine on symptoms of fibromyalgia via BDNF signaling in a fibromyalgia animal model.Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion.Innovative approaches to treatment - refractory depression: The ketamine story.Reconsidering anhedonia in depression: lessons from translational neuroscience.A review of current evidence for vilazodone in major depressive disorder.Of mice and men: modelling post-stroke depression experimentally.The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.Maternal separation in early life modifies anxious behavior and Fos and glucocorticoid receptor expression in limbic neurons after chronic stress in rats: effects of tianeptine.Novel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications.Disturbance of the glutamatergic system in mood disorders.Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration.GluA1 phosphorylation alters evoked firing pattern in vivo.The same antidepressant elicits contrasting patterns of synaptic changes in the amygdala vs hippocampus The Beneficial Impact of Antidepressant Drugs on Prenatal Stress-Evoked Malfunction of the Insulin-Like Growth Factor-1 (IGF-1) Protein Family in the Olfactory Bulbs of Adult Rats.Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule.L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.A review of antidepressant therapy in primary care: current practices and future directions.Effect of Tianeptine on Depressed Tinnitus Patients.The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression.Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development.Acute Toxicity From Intravenous Use of the Tricyclic Antidepressant Tianeptine.The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: the effect blocked by inhibitors of MAPK/ERK1/2 and PI3-K/Akt pathways.An astroglial basis of major depressive disorder? An overview.High-Speed imaging reveals opposing effects of chronic stress and antidepressants on neuronal activity propagation through the hippocampal trisynaptic circuit.Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress.

P2860

Q24605563-25184800-B4E3-48CE-9263-793B54F271E7 Q24633256-7FBDFBB0-B8D9-4C26-9133-361B41BBFE18 Q26769043-F1A0CFB6-4A11-47AD-ACD2-9DB7A59CC2CE Q27023257-0ADF66E5-AA0C-478C-AFC8-DDC76594B2B0 Q27025974-5FE8FCFB-AE03-46A8-A305-0B86FA35E4A4 Q27311267-AEDF53FC-EF7C-4CD3-88DB-52B0ADF45FF5 Q27337778-E62B4661-525A-42E8-86D2-FED27CAA00F1 Q28243936-E9E51693-396B-4B00-BA61-F86F348B9879 Q28268467-0DB50A1C-A570-4B88-81C9-A8D60808BF7B Q30437449-B2F6F555-55E1-485F-AE00-31693E77CA15 Q30534769-2DA35704-77E9-4D74-9C84-6FFBB54ACF50 Q30572014-5FDB63A5-B8E9-417B-B319-5C8E969C4E86 Q33658525-4DDE6EC1-D9B4-4DC8-87FF-06493452AE32 Q33899046-7E64DD5F-A924-47F4-8431-737A589AFBC7 Q34044050-BDC8ADDF-B824-4C88-B4F7-9E5474F6C1BA Q34082689-D03F201B-ADAE-4103-A717-7E8CE2702300 Q34124371-92C7344B-0B7D-41DB-B5F9-077680987B47 Q34338647-EA5D130D-E0A8-432B-A79C-1FB36839CBCD Q34407158-FD33D3A4-4B64-49CD-BF1B-024B1DD5AC8A Q34553463-4BBE0B79-55DD-44C1-B965-EB8D439C659D Q34673822-806CBFD4-FE69-4DD8-AEC7-F60C38F5A900 Q34980328-E5EB3849-6ABB-43C9-8432-45E6804C2763 Q35032598-D25CD70A-6481-4D7B-B0FA-2FCEB33B4B04 Q35149888-0ECD99CC-FB61-4479-B418-AFC9BB15A94C Q35693897-390F8D98-1388-4D47-B471-D104137B3116 Q35915045-0179EE79-5508-4A5C-AB47-F154509D7DA9 Q36323561-67A6956C-3F7A-416D-B7C4-805B6BCA1EA0 Q36460423-EEAF3D44-BD92-46F5-BBC0-A99FAD3960BB Q36712365-C021BB2A-575E-45F5-A916-8AFFCD5B251C Q36712802-C448B4B3-73FE-43BB-9430-DDE029527473 Q37070398-344CF526-9133-44D0-911B-829B30953DCE Q37251504-6AA31D97-50D3-47A4-9A21-391994F412FD Q37408016-D4F4582B-CB00-4DE7-BBE7-FB8078A906BC Q37891098-4D51AF75-DA19-47E8-AEB6-8FEC309174AD Q38246625-8AD4868C-94D8-4DB5-B16C-7F5BF0F229BC Q38679364-1F9EE52B-B5AC-4439-9DB0-C798875E56F0 Q39084387-0C242317-896E-4B3E-A9E8-3DB0EBD6B7FC Q39186841-BDBEA2BC-58D8-427D-B8A4-56BA69EE6423 Q39284185-C92364E7-1D4F-4CEE-B6A4-5C9F302BBEA4 Q41722126-68B67CB0-CC43-482E-A5AA-6B24E1E7ED63

P2860

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation

http://www.wikidata.org/entity/Q24613593

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The neurobiological properties ...... is to glutamatergic modulation

@ast

The neurobiological properties ...... is to glutamatergic modulation

@en

The neurobiological properties ...... is to glutamatergic modulation

@nl

type

label

The neurobiological properties ...... is to glutamatergic modulation

@ast

The neurobiological properties ...... is to glutamatergic modulation

@en

The neurobiological properties ...... is to glutamatergic modulation

@nl

prefLabel

The neurobiological properties ...... is to glutamatergic modulation

@ast

The neurobiological properties ...... is to glutamatergic modulation

@en

The neurobiological properties ...... is to glutamatergic modulation

@nl

P1433

Q24613593-C2B84000-29E2-4540-B6D3-0BDF95695367

P1476

Q24613593-8B3BB799-D644-4957-AE25-01D13460C737

P2093

Q24613593-03E1713E-47B5-4A70-BAA0-671078690CE3

Q24613593-14555838-4904-4FAC-B20A-7BB577249A79

Q24613593-154343A1-49DE-433F-9F22-478F73F6CDE1

Q24613593-25EAEA35-27EB-426C-A437-E169CA5B4E86

Q24613593-3BA363FF-229A-48AD-AD90-1571336A1246

Q24613593-4A76BCA4-C38A-4511-A52D-CDB99552719E

Q24613593-BEBEE508-8A9D-4678-941B-F28FC9B4E371

P2860

Q24613593-00F4DB37-84E4-49BC-A674-0EFE746166E6

Q24613593-0133BA55-C15D-4C57-A754-9D61B0DCCEDF

Q24613593-07CBA3A3-A22B-477C-BF08-9C0157D6DD0D

Q24613593-07E955C0-611F-4410-9F8B-00635456FE8A

Q24613593-08042D88-E551-4FFD-A620-1AEE7F04C603

Q24613593-086D44D0-2302-46C4-98B8-AE50232307D2

Q24613593-08A58A9E-812C-45AF-A3D0-D50BA686FE0F

Q24613593-093B4CF1-A68D-4EFA-A1CD-94311F9A10C1

Q24613593-0A4C5BF9-D8C9-450E-BE7C-EC510BC9BD71

Q24613593-0F4D0AFB-566D-46F3-8395-B77520F2FC56

P2888

Q24613593-4B2663F8-E1EF-45AD-960F-AF8A7AD6C248

P304

Q24613593-26C63507-CC31-415E-BCD5-A6FC52D33C70

P31

Q24613593-0DFD518B-B39A-4C3D-8F8F-3349D9FE3691

Q24613593-FBB5C4CC-F080-41E6-8307-9FCF8B989714

P3181

Q24613593-815B0821-A94F-4649-80BE-76DA5DDED05B

P356

Q24613593-78FF66C5-CF64-4202-ABDF-43C140E92F80

P407

Q24613593-4C481E09-E166-4336-B140-7094B712E256

P433

Q24613593-819DE700-DA39-4468-B49C-E40E30C94C98

P478

Q24613593-93353010-6D5F-48EA-9D31-93ADB160E0A6

P577

Q24613593-0D0FA984-7DB5-4D17-BE06-AE317434E3C9

Q24613593-7C368B6F-F95B-43DD-B7CD-0DD7100042FA

P5875

Q24613593-F910D100-13F2-4DEA-AAA2-17443383C851

P6179

Q24613593-2CDA8654-05FD-4588-BD9C-ED6CFF086495

P698

Q24613593-D633483E-64B9-4469-8C5E-8A5D24A34CD9

P921

Q24613593-03B87AAD-A9A9-49FB-922B-E85C7116D444

Q24613593-048CFB2D-7351-49FD-988F-B3DFBE2438A9

Q24613593-5BE470EF-1615-40D3-A49D-2A435CD503E3

Q24613593-9B4E8C7D-A929-411E-AC7B-D5CFD4E536D7

P932

Q24613593-541624A2-6256-473B-A881-BEBD4865E012

P3181

P356

P1433

Molecular Psychiatry

P1476

The neurobiological properties ...... is to glutamatergic modulation

@en

P2093

B S McEwen

http://www.w3.org/2001/XMLSchema#string

D M Diamond

http://www.w3.org/2001/XMLSchema#string

E Fuchs

http://www.w3.org/2001/XMLSchema#string

L P Reagan

http://www.w3.org/2001/XMLSchema#string

P Svenningsson

http://www.w3.org/2001/XMLSchema#string

S Chattarji

http://www.w3.org/2001/XMLSchema#string

T M Jay

http://www.w3.org/2001/XMLSchema#string

P2860

Signal transduction and genes-to-behaviors pathways in psychiatric diseases

The metabotropic glutamate receptors: structure, activation mechanism and pharmacology

Tianeptine: a review of its use in depressive disorders

Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine

Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine

Neurobiological and clinical effects of the antidepressant tianeptine

Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism

Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine

Tianeptine, a selective enhancer of serotonin uptake in rat brain

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

P2888

P304

237-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3743978

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/MP.2009.80

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26764524

http://www.w3.org/2001/XMLSchema#string

P6179

1013549477

http://www.w3.org/2001/XMLSchema#string

P698

19704408

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

2902200

http://www.w3.org/2001/XMLSchema#string